| abstract |
The present invention is a pharmaceutical composition for reducing pathological conditions in postmenopausal women, comprising lysine, proline, arginine, ascorbic acid, magnesium, green tea extract, N-acetyl-cysteine, selenium, copper, manganese, And a pharmaceutically acceptable ingredient selected from the group consisting of carriers, diluents and excipients, wherein the composition comprises 24-25 wt% lysine, 16-25 wt% A pharmaceutical composition comprising ascorbic acid and 22-25 wt% green tea extract is provided. A method of treatment using this pharmaceutical composition is also disclosed. |